MDMA

MDMA-assisted therapies are generating growing interest due to their potential to address deep trauma and emotional blockages that are difficult to treat with conventional methods. MDMA, administered in a structured clinical setting, can promote a state of emotional openness and reduce fear responses, facilitating the safe processing of difficult experiences.

This type of intervention is part of clinical programmes and regulated studies, where each session is accompanied by prior preparation, therapeutic guidance, and a subsequent integration process. In specialised and authorised settings, the aim is to provide a safe space to explore emotions, work through trauma, and promote significant changes in mental health, always within the current legal framework.

  • 📢 MINI CONFERENCE: PSYCHEDELICS AND MENTAL HEALTH 2026
    Clínica Synaptica avatar

    📢 MINI CONFERENCE: PSYCHEDELICS AND MENTAL HEALTH 2026

    On 20 March, Málaga will host a series of talks exploring the relationship between psychedelics and mental health. Specialists and professionals will discuss current research, their therapeutic potential and the challenges of…

  • Understanding MDMA-Assisted Psychotherapy
    Irene Pérez Mendez avatar

    Understanding MDMA-Assisted Psychotherapy

    MDMA, first synthesized in 1912, has moved from recreational use to becoming the focus of growing scientific interest for its therapeutic potential. Discover how it works, its role in PTSD treatment, and…

  • Rewiring the Soul: 5 Surprising Ways Psychedelics Reshape Who We Are
    José Carlos Bouso avatar

    Rewiring the Soul: 5 Surprising Ways Psychedelics Reshape Who We Are

    For centuries we believed personality was fixed, carved in stone by adulthood. A new systematic review — analyzing 48 studies on psilocybin, LSD, and ayahuasca — suggests otherwise: our deepest traits, from…

  • Fear, trauma and MDMA
    Òscar Parés Franquero avatar

    Fear, trauma and MDMA

    Fear is a fundamental emotion that protects us, but when it becomes chronic it can lead to disorders such as phobias and post-traumatic stress disorder (PTSD). Conventional treatments often show limited efficacy,…

  • Interview with Phil Wolfson
    Òscar Parés Franquero avatar

    Interview with Phil Wolfson

    Phil Wolfson, creator of Ketamine-Assisted Psychotherapy (KAP) and director of the Ketamine Research Foundation, shares his vision on the future of psychedelic psychotherapy in this in-depth interview. Drawing from decades of clinical…